» Articles » PMID: 3620596

Gastrointestinal Metabolism of N-acetylcysteine in the Rat, Including an Assay for Sulfite in Biological Systems

Overview
Publisher Wiley
Date 1987 Jul 1
PMID 3620596
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

The intestinal metabolism of N-acetylcysteine was studied in the rat. Isolated intestinal epithelial cells were shown to rapidly deacetylate [14C]-N-acetylcysteine to [14C]-cysteine, with slight oxidation of the latter to disulfide species. The cells did not accumulate reduced or oxidized cysteine, and N-acetylcysteine itself was not detected either free or in oxidized species intracellularly. Further metabolism of this NAC-derived cysteine to inorganic sulfite or glutathione was not detected. Following the administration of [14C]-N-acetylcysteine (50 mg/kg; 25 microCi) in vivo into the ilium, small quantities of both reduced and oxidized [14C]-N-acetylcysteine were demonstrated in hepatic portal vein plasma. [14C]-cysteine and inorganic sulfite were demonstrated as the major metabolites of N-acetylcysteine. These were present in the portal vein plasma at levels five and three times greater than the parent drug, respectively, 30 min after dosing. Additionally, [14C]-glutathione was shown to be a minor metabolite of N-acetylcysteine accumulating in portal vein plasma. These results may provide an explanation for the apparent low bioavailability of N-acetylcysteine when administered orally in humans and are discussed in terms of the origins of the protective effect of the drug in cases of paracetamol intoxication in humans.

Citing Articles

Morphine self-administration is inhibited by the antioxidant N-acetylcysteine and the anti-inflammatory ibudilast; an effect enhanced by their co-administration.

Quintanilla M, Morales P, Santapau D, Gallardo J, Rebolledo R, Riveras G PLoS One. 2024; 19(10):e0312828.

PMID: 39471200 PMC: 11521314. DOI: 10.1371/journal.pone.0312828.


Antioxidative effects of N-acetylcysteine in patients with β-thalassemia: A quick review on clinical trials.

Ghazaiean M, Aliasgharian A, Karami H, Ghasemi M, Darvishi-Khezri H Health Sci Rep. 2024; 7(10):e70096.

PMID: 39381531 PMC: 11458667. DOI: 10.1002/hsr2.70096.


Pharmacological Basis for Abrogating Myocardial Reperfusion Injury Through a Multi-Target Combined Antioxidant Therapy.

San-Martin-Martinez D, Serrano-Lemus D, Cornejo V, Gajardo A, Rodrigo R Clin Pharmacokinet. 2022; 61(9):1203-1218.

PMID: 35871676 DOI: 10.1007/s40262-022-01151-0.


Effects of -Acetyl-Cysteine Supplementation through Drinking Water on the Glutathione Redox Status during the Weaning Transition of Piglets.

Degroote J, Van Noten N, Wang W, De Smet S, Michiels J Antioxidants (Basel). 2019; 8(1).

PMID: 30654433 PMC: 6356391. DOI: 10.3390/antiox8010024.


Antioxidant therapeutic advances in COPD.

Rahman I Ther Adv Respir Dis. 2009; 2(6):351-74.

PMID: 19124382 PMC: 2744584. DOI: 10.1177/1753465808098224.